These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23869485)

  • 1. Structural insight into a novel human CCR5-V130I variant associated with resistance to HIV-1 infection.
    Stambouli N; Wei NN; Jlizi A; Aissa S; Abdelmalek R; Kilani B; Slim A; Tiouiri BA; Dridi M; Hamza A; Ben Ammar Elgaied A
    J Biomol Struct Dyn; 2014; 32(8):1202-10. PubMed ID: 23869485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insight into the binding complex: β-arrestin/CCR5 complex.
    Stambouli N; Dridi M; Wei NN; Jlizi A; Bouraoui A; Elgaaied AB
    J Biomol Struct Dyn; 2014; 32(6):866-75. PubMed ID: 24404772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis.
    Lagane B; Ballet S; Planchenault T; Balabanian K; Le Poul E; Blanpain C; Percherancier Y; Staropoli I; Vassart G; Oppermann M; Parmentier M; Bachelerie F
    Mol Pharmacol; 2005 Jun; 67(6):1966-76. PubMed ID: 15761117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
    Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
    J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine receptor CCR5: insights into structure, function, and regulation.
    Oppermann M
    Cell Signal; 2004 Nov; 16(11):1201-10. PubMed ID: 15337520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments.
    Imai M; Baranyi L; Okada N; Okada H
    Biochem Biophys Res Commun; 2007 Feb; 353(4):851-6. PubMed ID: 17210123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor conformation and constitutive activity in CCR5 chemokine receptor function and HIV infection.
    Flanagan CA
    Adv Pharmacol; 2014; 70():215-63. PubMed ID: 24931198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization.
    Hu Q; Napier KB; Trent JO; Wang Z; Taylor S; Griffin GE; Peiper SC; Shattock RJ
    J Mol Biol; 2005 Jul; 350(4):699-712. PubMed ID: 15964018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of new mutant sites of HIV-1 coreceptor CCR5 among Saudi populations.
    Abuelsaad AS; Al-Ghamdi AS; Al-Ghamdi AN; Alakkas EA; Alsulaimani AA; Al-Harthi AA; Abdel-Moneim AS
    J Interferon Cytokine Res; 2013 Dec; 33(12):783-9. PubMed ID: 23742258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach.
    Gadhe CG; Kothandan G; Cho SJ
    J Biomol Struct Dyn; 2013; 31(11):1251-76. PubMed ID: 23153179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage.
    Svicher V; Alteri C; Artese A; Zhang JM; Costa G; Mercurio F; D'Arrigo R; Alcaro S; Palù G; Clementi M; Zazzi M; Andreoni M; Antinori A; Lazzarin A; Ceccherini-Silberstein F; Perno CF;
    Antivir Ther; 2011; 16(7):1035-45. PubMed ID: 22024519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling of HIV-1 coreceptor CCR5 and exploring of conformational space of its extracellular domain in molecular dynamics simulation.
    Efremov RG; Legret F; Vergoten G; Capron A; Bahr GM; Arseniev AS
    J Biomol Struct Dyn; 1998 Aug; 16(1):77-90. PubMed ID: 9745897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
    Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
    J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5.
    Bönsch C; Munteanu M; Rossitto-Borlat I; Fürstenberg A; Hartley O
    PLoS One; 2015; 10(4):e0125396. PubMed ID: 25923671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.
    Gorry PR; Dunfee RL; Mefford ME; Kunstman K; Morgan T; Moore JP; Mascola JR; Agopian K; Holm GH; Mehle A; Taylor J; Farzan M; Wang H; Ellery P; Willey SJ; Clapham PR; Wolinsky SM; Crowe SM; Gabuzda D
    Virology; 2007 May; 362(1):163-78. PubMed ID: 17239419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of new mutant sites and 894C deletion variant genotyping of HIV-1 coreceptor CCR5 in indigenous Chinese populations].
    Liu M; Wang F; Hong W; Wang B; Jin L; Lei Z; Hou J
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1468-72. PubMed ID: 12509908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
    Platt EJ; Kuhmann SE; Rose PP; Kabat D
    J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino- and Carboxyl-Terminal CCR5 Mutations in Brazilian HIV-1-Infected Women and Homology Model of p.L55Q CCR5 Mutant.
    Costa GC; Nunes MR; Jesus JG; Novaes T; Cardoso JF; Sousa Júnior EC; Santos Ede S; Galvão-Castro B; Zanette DL; Gonçalves Mde S; Alcantara LC
    AIDS Res Hum Retroviruses; 2015 Jul; 31(7):685-91. PubMed ID: 25825809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.